Design, anticonvulsive and neurotoxic properties of retrobenzamides / N- (nitrophenyl)benzamides and N-(aminophenyl)benzamides

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 2, 1999, Pages 81-87

  Bourhim, Mustapha ^a   Poupaert, Jacques H ^b   Stables, James P ^c   Vallée, Louis ^d   Vamecq, Joseph ^a,d  

^a INSERM   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Ameltolide; Benzamides, anticonvulsive properties, neurotoxicity; Carbamazepine; N (Aminophenyl)benzamide; N (Nitrophenyl)benzamide; Phenytoin

Indexed keywords

AMELTOLIDE; ANILINE DERIVATIVE; BENZAMIDE DERIVATIVE; CARBAMAZEPINE; N (2 AMINOPHENYL)BENZAMIDE; N (2 METHYL 3 AMINOPHENYL)BENZAMIDE; N (2 METHYL 3 NITROPHENYL)BENZAMIDE; N (2 METHYL 4 AMINOPHENYL)BENZAMIDE; N (2 METHYL 4 NITROPHENYL)BENZAMIDE; N (2 METHYL 5 AMINOPHENYL)BENZAMIDE; N (2 METHYL 5 NITROPHENYL)BENZAMIDE; N (2 METHYL 6 AMINOPHENYL)BENZAMIDE; N (2 METHYL 6 NITROPHENYL)BENZAMIDE; N (2 NITROPHENYL)BENZAMIDE; N (3 AMINOPHENYL)BENZAMIDE; N (3 NITROPHENYL)BENZAMIDE; N (4 AMINOPHENYL)BENZAMIDE; N (4 NITROPHENYL)BENZAMIDE; PHENYTOIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE;

EID: 2142681083     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300365     Document Type: Article

References (23)

1. Hauser, W. A., Epilepsia 35 (Suppl. 2), S1 (1994)
2. Parrain, D., in: Les médicaments antiépileptiques chez l'enfant, G. Pons, O. Dulac, Y. Ben-Ary (eds.), pp. 27, Springer Verlag France, Paris (1994)
3. Löscher, W., Schmidt, D., Epilepsy Res. 2 145 (1988)
4. Louvel, J., in: Les médicaments antiépileptiques chez l'enfant, G. Pons, O. Dulac, Y. Ben-Ary (eds.), pp. 69, Springer Verlag France, Paris (1994)
5. Vallée, L., Cuvelier, J. C., Vamecq. J., in: Les médicaments antiépileptiques chez l'enfant, G. Pons, O. Dulac, Y. Ben-Ary (eds.), pp. 107, Springer Verlag France, Paris (1994)
6. Clark, C. R., Epilepsia 29, 198 (1988)
7. Leander, J. D., Lawson, R. R., Robertson, D. W., Neuropharmacology 27, 623 (1988)
8. Bourhim, M., Kanyonyo, M. D., Lambert, D. M. et al., J. Pharm. Belg. 52, 181 (1997)
9. Krall, R. L., Penry, J. K., White, B. G. et al., Epilepsia 19, 409 (1978)
10. Porter, R. J., Cereghino, J. J., Gladding, G. D. et al., Cleve. Clin. J. Med. 51, 293 (1984)
11. Kupferberg, H. J., Epilepsia 30 (Suppl. 1), S51 (1989)
12. White, H. S., Johnson, M., Wolf, H. H. et al., Ital. J. Sci. 16, 73 (1995)
13. Bailleux, V., Vallée, L., Nuyts, J. P. et al., Biomed. Pharmacother. 47, 463 (1993)
14. Bailleux, V., Vallée, L., Nuyts, J. P., Vamecq, J., Biomed. Pharmacother. 48, 95 (1994)
15. Bailleux, V., Vallée, L., Nuyts, J. P. et al., Chem. Pharm. Bull. 42, 1817 (1994)
16. Bailleux, V., Vallée, L., Nuyts, J. P. et al., Epilepsia 36, 559 (1995)
17. Diouf, O., Bourhim, M., Lambert, D. M. et al., Biomed. Pharmacother. 51, 131 (1997)
18. White, H. S., Woodhead, J. H., Franklin, M. R., in: Antiepileptic drugs 4th ed., R. Levy, R. Mattson, B. S. Meldrum (eds.), pp. 99. Raven Press, New York (1995)
19. Bailleux, V., Vallée, L., Nuyts, J. P. et al., Eur. J. Med. Chem. 30, 439 (1995)
20. Potts, B. D., Steve, G., Parli, C. J., Drug Metab. Disp. 17, 656 (1989)
21. Willow, M., Catterall, W. A., Mol. Pharmacol. 22, 627 (1982)
22. Brown, G. B., Int. Rev. Neurobiol. 29, 77 (1988)
23. Macdonald, R. L., Kelly, K. M., Epilepsia 36 (Suppl. 2), S2 (1995)